Gene · 4595
Papers3,741
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 3,741
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Frequency of Pathogenic Germline Mutations in Early and Late Onset Familial Breast Cancer Patients Using Multi-Gene Panel Sequencing: An Egyptian Study. | Genes (Basel) | 2022 | 36672847 | PubTator, text mining | PubMed |
| A study of gene variation in All-RAS wild-type metastatic colorectal cancer and its correlation with cetuximab. | J Gastrointest Oncol | 2022 | 36636055 | PubTator, text mining | PubMed |
| Clinical features and long-term outcomes of patients with colonic oligopolyposis of unknown etiology. | World J Gastroenterol | 2022 | 36632322 | PubTator, text mining | PubMed |
| Gene polymorphisms and prognosis of head and neck squamous cell carcinoma: a systematic review. | Rep Pract Oncol Radiother | 2022 | 36632296 | PubTator, text mining | PubMed |
| Polθ Inhibition: An Anticancer Therapy for HR-Deficient Tumours. | Int J Mol Sci | 2022 | 36613762 | PubTator, text mining | PubMed |
| Large Cancer Pedigree Involving Multiple Cancer Genes including Likely Digenic MSH2 and MSH6 Lynch Syndrome (LS) and an Instance of Recombinational Rescue from LS. | Cancers (Basel) | 2022 | 36612224 | PubTator, text mining | PubMed |
| Low Frequency of Cancer-Predisposition Gene Mutations in Liver Transplant Candidates with Hepatocellular Carcinoma. | Cancers (Basel) | 2022 | 36612198 | PubTator, text mining | PubMed |
| Hereditary Colorectal Cancer: State of the Art in Lynch Syndrome. | Cancers (Basel) | 2022 | 36612072 | PubTator, text mining | PubMed |
| Germline mutations in high penetrance genes are associated with worse clinical outcomes in patients with non-small cell lung cancer. | JTCVS Open | 2022 | 36590722 | PubTator, text mining | PubMed |
| Genomic features of mediastinal germ cell tumors: a narrative review. | Mediastinum | 2022 | 36582975 | PubTator, text mining | PubMed |
| Exploring biomarkers for prognosis and neoadjuvant chemosensitivity in rectal cancer: Multi-omics and ctDNA sequencing collaboration. | Front Immunol | 2022 | 36569844 | PubTator, text mining | PubMed |
| Clinical Impact of Next-Generation Sequencing Multi-Gene Panel Highlighting the Landscape of Germline Alterations in Ovarian Cancer Patients. | Int J Mol Sci | 2022 | 36555431 | PubTator, text mining | PubMed |
| Strong Hereditary Predispositions to Colorectal Cancer. | Genes (Basel) | 2022 | 36553592 | PubTator, text mining | PubMed |
| Hereditary Colorectal Cancer Syndromes: Molecular Genetics and Precision Medicine. | Biomedicines | 2022 | 36551963 | PubTator, text mining | PubMed |
| Mechanisms of Resistance in Gastroenteropancreatic Neuroendocrine Tumors. | Cancers (Basel) | 2022 | 36551599 | PubTator, text mining | PubMed |
| Cellular features of localized microenvironments in human meniscal degeneration: a single-cell transcriptomic study. | Elife | 2022 | 36548025 | PubTator, text mining | PubMed |
| Familial Adenomatous Polyposis: Case Report and Literature Review. | Cureus | 2022 | 36540528 | PubTator, text mining | PubMed |
| Novel THPO variant in hereditary thrombocytopenia: A potential candidate variant for predisposition to myeloid neoplasm. | PLoS One | 2022 | 36534659 | PubTator, text mining | PubMed |
| Complex molecular profile of DNA repair genes in epithelial ovarian carcinoma patients with different sensitivity to platinum-based therapy. | Front Oncol | 2022 | 36531044 | PubTator, text mining | PubMed |
| Germline and somatic variants in ovarian carcinoma: A next-generation sequencing (NGS) analysis. | Front Oncol | 2022 | 36531003 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4595/papers?page=33